{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:02:36Z","timestamp":1794560556523,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To determine the efficacy and safety of the Ologen collagen matrix adjunctive to Ahmed valve surgery. A randomized prospective multicentre clinical trial involving 58 patients that were followed for one year. Conventional surgery with Ahmed valve was performed in 31 eyes (Control group\/CG) and in 27 Ologen (Ologen group\/OG) was placed over the valve\u2019s plate. Baseline data: age, corneal thickness, intraocular pressure(IOP) and antiglaucoma medications.Postoperative data (days 1, 7 and months 1, 3, 6 and 12): IOP, antiglaucoma medications, visual acuity and complications were recorded. Frequency of hypertensive phase, complete and qualified success and survival rate were studied. No differences were found between CG and OG in the baseline data. The only difference between groups was a significantly lower IOP at day\u00a01. No other differences were found in the follow-up between groups. Hypertensive phase (56%CG and 55%OG, p\u2009=\u20090,947), complete success 28,6%CG and 30,4%OG (p\u2009=\u20090,88) and qualified success 96,4% and 95,9%(p\u2009=\u20090,794). Survival rates at 1 year were 76,7%(CG) and 69,2%(OG)(p\u2009=\u20090,531). 38,7% of patients in the CG suffered some complication during follow-up and 61,5% in OG(p\u2009=\u20090,086). Ologen does not increase safety or efficacy in Ahmed valve surgery at one-year follow-up. This is the first study that shows no benefit of Ologen adjunctive to this surgery.<\/jats:p>","DOI":"10.1038\/s41598-019-38656-x","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T11:05:29Z","timestamp":1551351929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy of Ologen matrix implant in Ahmed Glaucoma Valve Implantation"],"prefix":"10.1038","volume":"9","author":[{"given":"Marina","family":"Sastre-Ib\u00e1\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Cabarga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Canut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"P\u00e9rez-Bartolom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Urcelay-Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cordero-Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Garc\u00eda-Feij\u00f3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mar\u00eda","family":"Mart\u00ednez-de-la-Casa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"38656_CR1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ajo.2011.10.026","volume":"153","author":"SJ Gedde","year":"2012","unstructured":"Gedde, S. J. et al. Tube versus Trabeculectomy Study Group. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol 153, 789\u2013803 (2012).","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"38656_CR2","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.ajo.2014.02.027","volume":"157","author":"H Saheb","year":"2014","unstructured":"Saheb, H., Gedde, S. J., Schiffman, J. C. & Feuer, W. J. Tube Versus Trabeculectomy Study Group. Outcomes of glaucoma reoperations in the Tube Versus Trabeculectomy (TVT) Study. Am J Ophthalmol 157(6), 1179\u20131189 (2014).","journal-title":"Am J Ophthalmol"},{"key":"38656_CR3","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/S0161-6420(98)91049-1","volume":"105","author":"RS Ayyala","year":"1998","unstructured":"Ayyala, R. S. et al. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology 105, 1968\u201376 (1998).","journal-title":"Ophthalmology"},{"key":"38656_CR4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3928\/1542-8877-20020301-04","volume":"33","author":"RS Ayyala","year":"2002","unstructured":"Ayyala, R. S. et al. Comparison of double-plate Molteno and Ahmed glaucoma valve in patients with advanced uncontrolled glaucoma. Ophthalmic Surg Lasers 33, 94\u2013101 (2002).","journal-title":"Ophthalmic Surg Lasers"},{"key":"38656_CR5","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0002-9394(03)00630-5","volume":"136","author":"K Nouri-Mahdavi","year":"2003","unstructured":"Nouri-Mahdavi, K. & Caprioli, J. Evaluation of the hypertensive phase after insertion of the Ahmed glaucoma valve. Am J Ophthalmol 136, 1001\u20131008 (2003).","journal-title":"Am J Ophthalmol"},{"key":"38656_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1046\/j.1440-1606.1999.00230.x","volume":"27","author":"AC Molteno","year":"1999","unstructured":"Molteno, A. C., Dempster, A. G. & Carne, A. Molteno implants: the principles of bleb management. Aust N Z J Ophthalmol 27, 350\u2013353 (1999).","journal-title":"Aust N Z J Ophthalmol"},{"key":"38656_CR7","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.ophtha.2003.09.037","volume":"111","author":"VP Costa","year":"2004","unstructured":"Costa, V. P., Azuara-Blanco, A., Netland, P. A., Lesk, M. R. & Arcieri, E. S. Efficacy and safety of adjunctive mitomycin C during Ahmed glaucoma valve implantation: a prospective randomized clinical trial. Ophthalmology 111, 1071\u20131076 (2004).","journal-title":"Ophthalmology"},{"issue":"10","key":"38656_CR8","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1016\/j.ophtha.2009.03.030","volume":"116","author":"F Al-Mobarak","year":"2009","unstructured":"Al-Mobarak, F. & Kahn, A. O. Two-year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative mitomycin-C. Ophthalmology 116(10), 1862\u20135 (2009).","journal-title":"Ophthalmology"},{"key":"38656_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ajo.2008.04.008","volume":"146","author":"JA Alvarado","year":"2008","unstructured":"Alvarado, J. A., Hollander, D. A. & Juster, R. P. & Lillian, C.L. Ahmed Valve Implantation with Adjunctive Mitomycin C and 5-Fluorouracil: Long- term Outcomes. Am J Ophthalmol 146, 276\u2013284 (2008).","journal-title":"Am J Ophthalmol"},{"key":"38656_CR10","doi-asserted-by":"publisher","first-page":"e85782","DOI":"10.1371\/journal.pone.0085782","volume":"9","author":"M He","year":"2014","unstructured":"He, M., Wang, W., Zhan, X. & Huang, W. Ologen implant versus mitomycin C for trabeculectomy: A systematic review and meta-analysis. PLoS One 9, e85782 (2014).","journal-title":"PLoS One"},{"key":"38656_CR11","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/eye.2011.219","volume":"25","author":"S Cillino","year":"2011","unstructured":"Cillino, S., Di Pace, F., Cillino, G. & Casuccio, A. Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month randomized clinical trial. Eye 25, 1598\u20131606 (2011).","journal-title":"Eye"},{"key":"38656_CR12","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00417-010-1385-y","volume":"248","author":"A Rosentreter","year":"2010","unstructured":"Rosentreter, A., Mellein, A. C., Konen, W. W. & Dietlein, T. S. Capsule excision and Ologen implantation for revision after glaucoma drainage device surgery. Graefes Arch Clin Exp Ophthalmol 248, 1319\u20131324 (2010).","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"38656_CR13","first-page":"2404","volume":"41","author":"WC Hsu","year":"2000","unstructured":"Hsu, W. C., Spilker, M. H., Yannas, I. V. & Rubin, P. A. Inhibition of conjunctival scarring and contraction by a porous collagenglycosaminoglycan implant. Invest Ophthalmol Vis Sci 41, 2404\u20132411 (2000).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"38656_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0002-9394(14)73755-9","volume":"120","author":"AL Coleman","year":"1995","unstructured":"Coleman, A. L. et al. Initial clinical experience with the Ahmed Glaucoma Valve implant. Am J Ophthalmol 120, 23\u201331 (1995).","journal-title":"Am J Ophthalmol"},{"key":"38656_CR15","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1167\/iovs.15-17480","volume":"56","author":"S Rho","year":"2015","unstructured":"Rho, S., Sung, Y., Tak, M. K., Rho, S. H. & Kim, C. Y. Bleb Analysis and Short-Term Results of Biodegradable Collagen Matrix\u2013Augmented Ahmed Glaucoma Valve Implantation: 6-Month Follow-up. Invest Ophthalmol Vis Sci. 56, 5896\u20135903 (2015).","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"2","key":"38656_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3109\/02713683.2010.512115","volume":"36","author":"FC DeCroos","year":"2010","unstructured":"DeCroos, F. C. et al. In Vitro Fluid Dynamics of the Ahmed Glaucoma Valve Modified with Expanded Polytetrafluoroethylene. Current Eye Research 36(2), 112\u2013117 (2010).","journal-title":"Current Eye Research"},{"key":"38656_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00061198-200402000-00008","volume":"13","author":"HS Syed","year":"2004","unstructured":"Syed, H. S., Law, S., Nam, S. H., Li, G. & Caprioli, J. A. Baerveldt-350 versus Ahmed Valve for Refractory Glaucoma Coleman, A. Baerveldt-350 versus Ahmed Valve for Refractory Glaucoma. J Glaucoma 13, 38\u201345 (2004).","journal-title":"J Glaucoma"},{"key":"38656_CR18","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.ophtha.2006.04.020","volume":"113","author":"K Ishida","year":"2006","unstructured":"Ishida, K. et al. Comparison of polypropylene and silicone Ahmed Glaucoma Valves. Ophthalmology. 113, 1320\u20131326 (2006).","journal-title":"Ophthalmology."},{"key":"38656_CR19","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.ophtha.2011.05.004","volume":"118","author":"PG Christakis","year":"2011","unstructured":"Christakis, P. G. et al. The Ahmed Versus Baerveldt Study. One-year treatment outcomes. Ophthalmology 118, 2180\u20132189 (2011).","journal-title":"Ophthalmology"},{"key":"38656_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.survophthal.2004.10.006","volume":"50","author":"CH Hong","year":"2005","unstructured":"Hong, C. H., Arosemena, A., Zurakowski, D. & Ayyala, R. S. Glaucoma drainage devices: a systematic literature review and current controversies. Surv Ophthalmol 50, 48\u201360 (2005).","journal-title":"Surv Ophthalmol"},{"key":"38656_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/IJG.0000000000000249","volume":"25","author":"H Won","year":"2016","unstructured":"Won, H. & Sung, K. Hypertensive Phase Following Silicone Plate Ahmed Glaucoma Valve Implantation. J Glacuoma 25, 313\u2013317 (2016).","journal-title":"J Glacuoma"},{"key":"38656_CR22","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.ophtha.2007.10.034","volume":"115","author":"RJ Goulet","year":"2008","unstructured":"Goulet, R. J., Phan, A. D., Cantor, L. B. & WuDunn, D. Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant. Ophthalmology 115, 1141\u20131147 (2008).","journal-title":"Ophthalmology"},{"key":"38656_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S0002-9394(03)00239-3","volume":"136","author":"MR Wilson","year":"2013","unstructured":"Wilson, M. R., Mendis, U., Paliwal, M. & Haynatzka, V. Long-term Follow-up of primary glaucoma surgery with Ahmed glacuoma valve implant versus trabeculectomy. Am J Ophthalmol 136, 464\u2013470 (2013).","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"38656_CR24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ajo.2007.07.035","volume":"144","author":"C Souza","year":"2007","unstructured":"Souza, C. et al. Long- term outocmes of Ahmed galucoma valve implantation in refractory glaucomas. Am J Ophtalmol 144(6), 893\u2013900 (2007).","journal-title":"Am J Ophtalmol"},{"key":"38656_CR25","doi-asserted-by":"crossref","unstructured":"Epstein, E. Fibrosis response to aqueous. Its relationship to glaucoma. Br J Ophthalmol 43, 641\u20137 (1959).","DOI":"10.1136\/bjo.43.11.641"},{"key":"38656_CR26","doi-asserted-by":"crossref","unstructured":"Pakravan, M., Salehi, R. S., Yazdani, S., Ghahari, E. & Yaseri, M. Effect of Early Treatment with Aqueous Suppressants on Ahmed Glaucoma Valve Implantation Outcomes. Ophthalmology 121,1693\u20131698 (2014).","DOI":"10.1016\/j.ophtha.2014.03.014"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38656-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38656-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38656-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:46:11Z","timestamp":1671259571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38656-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["38656"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-38656-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]},"assertion":[{"value":"13 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3178"}}